AJP - Regu Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 274: R775-R782, 1998;
0363-6119/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louis, C. A.
Right arrow Articles by Albina, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, C. A.
Right arrow Articles by Albina, J. E.
Vol. 274, Issue 3, R775-R782, March 1998

Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension

Claudine A. Louis1, Jonathan S. Reichner1, William L. Henry Jr.1, Balduino Mastrofrancesco1, Tomomi Gotoh2, Masataka Mori2, and Jorge E. Albina1

1 Department of Surgery, Division of Surgical Research, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island 02903; and 2 Department of Molecular Genetics, Kumamoto University School of Medicine, Kohonji, Kumamoto 862, Japan

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Experiments were performed to identify arginase isoforms expressed in primary and transformed rodent macrophages and to determine the molecular mechanisms for the previously observed increase in arginase activity in macrophages cultured in hypoxia or anoxia. Results demonstrate the following: 1) mRNA and protein for hepatic-type AI arginase are expressed in primary cultures of rat and mouse peritoneal macrophages and are enhanced seven- and ninefold, respectively, by lipopolysaccharide (LPS). 2) mRNA for extrahepatic-type AII arginase is constitutively expressed in mouse, but not rat, peritoneal macrophages and is detected in RAW264.7 cells after LPS treatment; neither J774A.1 nor P388D1 cells contain arginase mRNA. 3) AI arginase mRNA, arginase activity in cell lysates, and L-arginine flux through arginase in intact cells are all increased in rat wound-derived and mouse peritoneal macrophages by hypoxic or anoxic culture; AII arginase mRNA is, in contrast, suppressed >50% by O2 deprivation. 4) Expression of the L-arginine transporter mCAT-2 is increased greater than twofold by reduced O2 culture. These results demonstrate substantial variability in arginase isoform expression among primary and transformed rodent macrophages. They also identify AI and AII arginase and the mCAT-2 L-arginine transporter as O2-regulated genes.

arginine; macrophage; hypoxia

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

SINCE THE DESCRIPTION of arginase (L-arginine-urea hydrolase, EC 3.5.3.1) in tumors and granulation tissue by Edlbacher and Merz (16), two independent paradigms propose a role for this enzyme in the regulation of specific and nonspecific immunity. According to the first paradigm, macrophage arginase consumes and depletes extracellular L-arginine to concentrations that are rate limiting for the proliferation or survival of lymphocytes, microorganisms, or tumor cells (12, 13).

The second, most recent, proposal indicates that it is nitric oxide (NO) or its derivatives, produced by macrophages from L-arginine by the inducible form of NO synthase (NOS), that mediate the macrophage's suppressor phenotype and its antimicrobial and antitumor properties (1, 2, 6, 11). It has been hypothesized, in this connection, that arginase modulates NO production in macrophages by reducing the intracellular availability of L-arginine to inducible NOS (33). In explaining the physiological role of arginase in tumors, wounds, and other sites of inflammation, both models agree in identifying the macrophage as the cell expressing arginase in the aforementioned immune responses.

Although the presence of arginase in macrophages has been known for 20 years (28), controversy remains as to the precise isoform of the enzyme that is expressed in these cells. At least two major isozymes of arginase have been described, an hepatic AI isoform and an extrahepatic AII isoform. These isozymes are encoded by different genes and do not appear to emerge from alternative splicing or posttranslational modification of the same gene product (14). Early work by Chen and Broome (9) indicated profound similarities between arginases purified from murine peritoneal macrophages and liver in terms of molecular weight, kinetic characteristics, and Mn2+ requirements. However, it has been generally accepted that macrophage arginase is distinct from the AI isoform present in the cytosol of liver cells (25), a conclusion drawn mainly from the lack of detection of AI in macrophages using antibodies generated against hepatic arginase (7). It has been proposed that, by possessing comparable immunologic and molecular properties, macrophage arginase is similar or identical to the AII, kidney-type mitochondrial isoform of the enzyme (22). Work by Wang et al. (41) and Gotoh et al. (22) identified AII as the isoform expressed by lipopolysaccharide (LPS)-stimulated RAW 264.7 cells, a murine macrophage cell line. Most recently, Sonoki et al. (38) reported the presence of AI in rat peritoneal macrophages.

Previous work from this laboratory indicated that 1) arginase is the predominant, if not exclusive, pathway of L-arginine metabolism in maturing wounds (5); 2) macrophages contain most cell-associated arginase in wounds (4); and 3) the metabolism of L-arginine through arginase by wound-derived macrophages is greatly enhanced during anoxic culture (3). Motivated by these findings, experiments were performed to identify the arginase isoforms expressed in primary and transformed rodent macrophages and to investigate the molecular mechanisms for the O2-dependent modulation of L-arginine metabolism in these cells.

Results to be shown demonstrate the differential expression of distinct arginase isoforms among macrophage populations. Macrophages obtained from healing wounds or from the peritoneal cavity of rats expressed only AI mRNA and protein. Murine peritoneal macrophages, in contrast, expressed mRNA for both the AI and AII isoforms. Both isoforms were induced after LPS stimulation. Because of the frequent use of cell lines for the study of L-arginine metabolism and NO production by macrophages (22, 29, 32, 41), three commonly employed transformed murine cell lines, RAW264.7, P388D1, and J774A.1, were included in these studies. Neither AI nor AII mRNA was constitutively present in these cells. RAW 264.7 cells, but not P388D1 or J774A.1 cells, expressed AII mRNA after LPS stimulation. AI mRNA was not detected in any of the cell lines after LPS treatment.

In reference to the increased L-arginine metabolism through arginase in O2-deprived cultures, results to be presented demonstrate that AI and the L-arginine transporter mCAT-2 (31) were induced in hypoxic or anoxic culture, whereas AII mRNA was decreased under these conditions.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Animals

Male Fischer rats (150-200 g, VAF-Plus, Charles River Laboratories, Wilmington, MA) and male B6D2F1 mice (Taconic, Germantown, NY) were used in all experiments. Animals were certified free of common rodent pathogens by the suppliers and were housed in an isolation environment on arrival at the laboratory. The animals were monitored by Brown University/Rhode Island Hospital (Providence, RI) veterinary personnel.

Wound Model, Cells, and Cell Culture

The experimental wound used was the subcutaneously implanted polyvinyl alcohol (PVA) sponge model that has previously been described (4). Briefly, 10 circular sterile PVA sponges (Unipoint Industries, High Point, NC) measuring ~1 cm in diameter and 5 mm in thickness were implanted subcutaneously in the dorsum of anesthetized rats through a midline skin incision. The sponge wounds were retrieved 10 days after wounding, and wound-derived macrophages were harvested from the sponges as described (4). Peritoneal macrophages were obtained from nonwounded rats and mice by peritoneal lavage (1, 4). The murine macrophage cell lines RAW264.7, P388D1, and J774A.1 were obtained from American Type Culture Collection (Rockville, MD). Cells were incubated overnight in culture medium [RPMI-1640 (Life Technologies, Grand Island, NY) with 1% bovine serum albumin (BSA, Sigma, St. Louis, MO) or 1% fetal calf serum (HyClone Laboratories, Logan, UT), 5 × 10-5 M 2-mercaptoethanol, 10 mM 3-(N-morpholino)propanesulfonic acid, and antibiotics, pH 7.4] at a density of 2 × 106/ml. Culture medium contained <3 pg/ml endotoxin as detected by a chromogenic assay (QCL1000, Wittaker M. A. Bioproducts, Walkersville, MD). Culture medium was supplemented with 10 µg/ml LPS (Escherichia coli serotype 0128:B12, Sigma) or 100 µM cobalt chloride (Sigma) when so indicated.

Macrophages were cultured under normoxic, hypoxic, or anoxic conditions. For hypoxic and anoxic cultures, cells were plated in 6-cm Permanox culture plates (Nunc, Naperville, IL), and these were placed in gastight modular incubator chambers (Billups-Rothenberg, Del Mar, CA). The chambers were then gassed for 2 h using certified gases containing 1 or 0% O2-5% CO2-balance N2. The final PO2 levels in culture media were 8.3 and 0 Torr, respectively. The gassing ports were then closed, and the chambers were placed in a 37°C temperature-controlled incubator overnight. Normoxic cultures were incubated at 37°C in 5% CO2 in room air.

RNA Isolation

Total RNA was isolated from 15-20 × 106 cells or 1 g of kidney tissue using the reagent Ultraspec (Biotecx, Houston, TX) according to manufacturer's recommendations. Total RNA from liver tissue was provided by Dr. Nancy Thompson (Dept. of Medical Oncology, Brown University, Providence, RI).

Probes for Northern Blot Analysis

AI. The probe used to detect AI was prepared by polymerase chain reaction (PCR). Sense and antisense primers used for PCR amplification of rat macrophage arginase were 5'-CCAATAGAGATTATCGGAGCG-3' and 5'-CAGTTCCTTCAGGAGAAAGGC-3', which correspond to residues 7-13 and 140-146 of the reported hepatic arginase amino acid sequence (27). These primers were synthesized by the Clinical Molecular Biology Department at Rhode Island Hospital (Providence, RI). The PCR product was amplified using cDNA from rat wound-derived macrophages. The cDNA was generated with a First-Strand Synthesis Kit (Pharmacia, San Francisco, CA) from total RNA, according to manufacturer's directions. The PCR product was subcloned into a pCR-II plasmid vector (Invitrogen, San Diego, CA), and plasmid DNA was isolated with a Qiagen plasmid kit according to manufacturer's directions (Qiagen, Chatsworth, CA). The insert was analyzed by restriction mapping and nucleotide sequencing by Seqwright (Houston, TX).

AII. A plasmid (pGEM-rAII-1) containing a 248-base pair (bp) fragment of rat AII cDNA shown to detect AII mRNA in RAW264.7 cells was employed (22).

mCAT-2. A pBluescript plasmid (clone 20.5.1) containing cDNA to mCAT-2 was a gift from Dr. Carol MacLeod (University of California, San Diego, La Jolla, CA). Bal I digestion of the plasmid yielded a 2-kilobase (kb) cDNA insert that recognizes two transcripts of ~4.5 and 8.5 kb (18, 30).

18S ribosomal RNA. A pUC830 plasmid containing the mouse 18S ribosomal (r) cDNA (34) was obtained from American Type Culture Collection. Sph I and BamH I digestion of the plasmid yielded a 752-bp cDNA insert that detects 18S rRNA in rat and mouse macrophages (unpublished results). Measurement of 18S ribosomal RNA was used as a control for variations in the amount of RNA loaded in each lane.

Northern Blot Analysis

Total RNA (20 µg) was fractionated by 1% agarose-0.66% formaldehyde gel electrophoresis (39), transferred to a nylon membrane, and immobilized by ultraviolet cross-linking. AI, AII, mCAT-2, and 18S rRNA were detected with the cDNA probes described above radiolabeled with [32P]dCTP by random priming (Pharmacia). The membrane was hybridized in hybridization buffer [50% deionized formamide, 50 mM tris(hydroxymethyl)aminomethane hydrochloride (pH 7.5), 100 mg/ml dextran sulfate, 58 mg/ml sodium chloride, 10 mg/ml sodium dodecyl sulfate (SDS), 2 mg/ml BSA, 2 mg/ml polyvinylpyrrolidone, 2 mg/ml Ficoll (400,000 mol wt), 1 mg/ml sodium pyrophosphate, and 0.25 mg/ml denatured salmon sperm DNA] containing radiolabeled probe (10 ng/ml) for 18-24 h. The membrane was washed for two 30-min periods with 2 × saline-sodium citrate (SSC) at room temperature followed by two 30-min periods with 2 × SSC-1.0% SDS at 65°C. The membrane was autoradiographed at -80°C. AI, AII, mCAT-2, and 18S rRNA were quantitated by densitometry using a Protein Databases desktop densitometer and Quantity 1D gel analysis software (PDI, Huntington Station, NY).

Western Blot Analysis

Postnuclear supernatants of cell lysates (30 µg of protein/lane) were size fractionated in 15% SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (3). Membranes were incubated for 1 h in buffer A [phosphate-buffered saline (PBS, pH 7.5)-0.3% Tween 20] and then for 1 h with a rabbit antibody (Ab) against human hepatic AI previously shown to detect AI in rat macrophages (38). The Ab was diluted 1/1,000 in buffer B [PBS (pH 7.5)-0.05% Tween 20]. The membranes were washed with buffer B and incubated with a goat anti-rabbit Ab conjugated with alkaline phosphatase (1/1,000) for 1 h in buffer B. AI was detected on reaction with nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. Immunoreactive AI was quantitated by densitometry as described above. Protein was determined with the Bicinchoninic Acid Protein Assay Reagent A (Pierce Chemical, Rockford, IL).

Arginase Activity

Arginase activity was measured in cell lysates with a radiometric assay using L-[guanido-14C]arginine according to Russell and Ruegg (36). Arginase activity gives rise to [14C]urea and unlabeled ornithine. Radiolabeled urea was separated from L-[guanido-14C]arginine by ion-exchange chromatography (36).

L-Arginine Metabolism by Cultured Cells

Macrophages were incubated overnight under normoxic, hypoxic, or anoxic conditions. Culture supernatants were then removed, and media containing 0.5 µCi/ml L-[guanido-14C]arginine and the NOS inhibitor NG-monomethyl-L-arginine (0.5 mM, Calbiochem, La Jolla, CA) were added to the cells. Culture supernatants were harvested and analyzed for [14C]urea by high-performance liquid chromatography after 2 h of culture at 37°C in 5% CO2 in air. No radiolabeled L-citrulline, the product of the NOS reaction, was found in supernatants. Flux of L-arginine through arginase was calculated from the accumulation of radiolabeled urea and the initial L-arginine specific radioactivity in culture media.

Data Presentation and Analysis

Data shown are representative of at least two independent experiments. Quantitative data are means ± SD from quadruplicate samples in a representative experiment. Statistical analysis was performed using analysis of variance.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

AI mRNA Expression in Rat Wound-Derived Macrophages

A cDNA probe for Northern blot analysis of rat macrophage arginase was generated by PCR and cloned. The PCR fragment was generated with cDNA from rat wound-derived macrophages using primers designed to amplify a region of liver arginase that encodes for three histidine residues, which are highly conserved among all known arginase amino acid sequences (25). These histidine residues function both as ligands for the binuclear Mn2+ reaction center and as general base catalysts (8). The cloned fragment was radiolabeled and used in a Northern blot to detect mRNA isolated from rat wound-derived macrophages, liver, and kidney. Figure 1 shows that wound-derived macrophages expressed a transcript identical in size to that found in rat liver (~1.6 kb). No mRNA transcript was detected in kidney RNA preparation. Sequencing of the cloned fragment confirmed that the detected mRNA was AI, because the sequence of the 440-bp cloned fragment was identical to the corresponding region of rat liver arginase cDNA (27).


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 1.   Rat wound-derived macrophages express AI arginase mRNA. Total RNA isolated from cultured wound-derived rat macrophages (M), rat liver (L), and rat kidney (K) was subjected to Northern blot analysis as described under MATERIALS AND METHODS. AI mRNA was detected with cloned cDNA insert described in MATERIALS AND METHODS. A transcript, 1.6 kilobase (kb) in size, was detected in total RNA isolated from rat macrophages and liver. Positions of 28S and 18S rRNA are shown on left. Membrane was stripped, and 18S rRNA was measured to control for variations in amount of RNA in each lane.

Arginase mRNA Expression in Primary Cultured and Transformed Macrophages

AI and AII mRNA expression was measured in the different macrophage populations indicated in Fig. 2 after overnight culture in the absence or presence of LPS. AI mRNA was detected only in primary cultures of rat and mouse peritoneal macrophages and induced by LPS treatment seven- and ninefold, respectively. AII mRNA was expressed in mouse peritoneal macrophages and induced approximately threefold by treatment with LPS. In confirmation of the results of Sonoki et al. (38), AII mRNA was not detected in rat macrophages cultured in the presence or absence of LPS. As has been observed previously, AII mRNA was induced in RAW264.7 macrophages after LPS treatment (22). Neither AI nor AII mRNA was expressed in P388D1 or J774A.1 cells in the presence or absence of LPS.


View larger version (73K):
[in this window]
[in a new window]
  		Fig. 2.   Species-specific expression of AI and AII mRNA in macrophages. Total RNA was isolated from rat and mouse peritoneal macrophages, RAW264.7, P388D1, and J774A.1 cells cultured overnight with or without lipopolysaccharide (LPS), as described under MATERIALS AND METHODS. AI and AII mRNA and 18S rRNA were detected by Northern blot analysis as indicated under MATERIALS AND METHODS. Densitometric values for AI and AII normalized to 18S rRNA were as follows: AI: 9.2 for rat peritoneal macrophages, 63.4 for rat peritoneal macrophages + LPS, 2.5 for mouse peritoneal macrophages, and 23.1 for mouse peritoneal macrophages + LPS; AII: 2.1 for mouse peritoneal macrophages, 5.8 for mouse peritoneal macrophages + LPS, and 5.1 for RAW264.7 + LPS. mRNA was not detected in remaining cells or culture conditions.

AI Protein Expression in Macrophages

Immunoreactive AI was also measured in cell lysates obtained in the experiment described above (Fig. 3). The anti-AI polyclonal Ab immunoreacted with two proteins of ~35 and 38 kDa in rat hepatocyte lysates, as previously shown by Sonoki et al. (38). Immunoreactive proteins of identical molecular mass were detected in mouse peritoneal macrophage cell lysates and increased twofold after treatment with LPS. A single protein, 35 kDa in size, was detected in rat peritoneal macrophages and was increased twofold after LPS treatment. In agreement with the Northern blot analysis, immunoreactive AI was not detected in cell lysates from the murine macrophage cell lines (results not shown).


View larger version (8K):
[in this window]
[in a new window]
  		Fig. 3.   Immunoreactive AI is expressed in cultured peritoneal macrophages but not in transformed cells. Cell lysates were prepared from rat and mouse peritoneal macrophages or RAW264.7, P388D1, and J774A.1 macrophages cultured overnight with or without LPS. Immunoreactive AI was detected as described in MATERIALS AND METHODS. Densitometric values (OD × mm2) for each cell type and treatment were as follows: 0.22 for rat peritoneal macrophages, 0.43 for rat peritoneal macrophages + LPS, 1.89 for mouse peritoneal macrophages, and 3.59 for mouse peritoneal macrophages + LPS.

Induction of Arginase by Anoxia or Hypoxia

This laboratory previously reported that L-arginine metabolism through arginase in rat wound-derived macrophages increases substantially during anoxic culture (3). Data in Fig. 4 demonstrate that increases in L-arginine metabolism through arginase in these cells after anoxic culture is associated with a greater than twofold increase in immunoreactive AI protein. Similar to hepatocytes, two proteins of ~35 and 38 kDa, were detected by the Ab in rat wound-derived macrophage lysates. In addition, results shown in Fig. 4 indicate that cobalt chloride, a compound that mimics the effects of hypoxia on the expression of some hypoxia-inducible genes (20, 21), increased immunoreactive AI to the same extent as anoxia.

To investigate the molecular level of arginase regulation by O2 and also to explore whether absolute anoxia is required for enzyme induction, AI and AII mRNA were measured by Northern blot analysis in rat wound-derived macrophages and mouse peritoneal macrophages cultured under hypoxic (1% O2) or anoxic conditions. As shown in Fig. 5, hypoxia and anoxia increased AI mRNA expression in rat wound-derived macrophages 2.5- and 7.5-fold, respectively. AI mRNA expression was also induced by hypoxia and anoxia (4.5-fold) in mouse peritoneal macrophages. In marked contrast and demonstrating differences in the regulation of the two arginase genes, AII mRNA detected in murine cells was decreased by hypoxia and anoxia by 50 and 85%, respectively (Fig. 5).

Arginase Activity vs. Metabolic Flux in Cultured Macrophages

Arginase activity was measured in lysates from rat wound-derived and rat and mouse peritoneal macrophages cultured overnight in normoxic, hypoxic, or anoxic conditions. In the same experiments and at the end of the overnight culture, identically treated intact cells were incubated with L-[guanido14C]arginine, and the accumulation of its metabolite [14C]urea in culture supernatants was measured after 2 h. Arginase activity in cell lysates increased over values found in normoxic cultures in both hypoxic and anoxic cultures and did so to a similar extent (Table 1). The metabolism of L-arginine through arginase by the intact cells was greater in cells cultured in anoxia compared with those cultured under normoxic or hypoxic conditions. Incidentally and in agreement with Schneider and Dy (37) and others (4), arginase activity was not detected in culture supernatants harvested after overnight culture (results not shown).


View larger version (12K):
[in this window]
[in a new window]
  		Fig. 4.   Anoxia and cobalt increase immunoreactive arginase in rat wound-derived macrophages. Cell lysates were prepared from macrophages cultured overnight under normoxic or anoxic conditions or in presence of 100 µM cobalt chloride. Immunoreactive AI was measured in cell lysates as described under MATERIALS AND METHODS. Densitometric values (OD × mm2) for each of different treatments were as follows: 0.49 for normoxia, 1.43 for cobalt, and 1.38 for anoxia.


View larger version (59K):
[in this window]
[in a new window]
  		Fig. 5.   Hypoxia (1% O2) and anoxia increase AI mRNA expression in rat wound-derived macrophages and mouse peritoneal macrophages, whereas AII mRNA is suppressed by O2 deprivation. RNA was isolated from macrophages cultured overnight under normoxic, hypoxic, or anoxic conditions. AI and AII mRNA and 18S rRNA were detected by Northern blot analysis as described under MATERIALS AND METHODS. Densitometric values for AI and AII normalized to 18S rRNA were as follows: AI in rat wound-derived macrophages: 15.0 for 21% O2, 40.0 for 1% O2, and 112.2 for 0% O2; AI in mouse peritoneal macrophages: 20.9 for 21% O2, 97.4 for 1% O2, and 113.0 for 0% O2; AII in mouse peritoneal macrophages: 78.4 for 21% O2, 39.3 for 1% O2, and 9.5 for 0% O2.

Regulation of Arginine Transporter mRNA by Anoxia and Hypoxia

To determine whether transport of L-arginine into the cell could be preferentially induced by anoxia, mCAT-2 mRNA was measured in rat wound-derived macrophages and mouse peritoneal macrophages after overnight culture under normoxic, hypoxic, or anoxic conditions. mCAT-2 encodes an Na+-independent cationic amino acid transporter that has been shown to be inducible in RAW264.7 cells by interferon-gamma (IFN-gamma ) and LPS (31). As stated in MATERIALS AND METHODS, the radiolabeled probe detects two mRNA transcripts of ~4.5 and 8.5 kb. Both of these transcripts were increased in rat wound-derived and mouse peritoneal macrophages by hypoxic and anoxic culture, with the changes being more prominent for the 8.5-kb transcript. This transcript was increased after hypoxic or anoxic culture 2- and 5.5-fold, respectively, in rat wound-derived macrophages and 3.5- and 2-fold, respectively, in mouse peritoneal macrophages.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Current results extend previous findings demonstrating the presence of arginase in rodent macrophages (reviewed in Ref. 25). Moreover, they identify the expression of mRNA for both isoforms of arginase, AI and AII, in murine peritoneal macrophages, the exclusive presence of AI in rat macrophages, and disparity in arginase expression among murine macrophage cell lines.

In addition to the lack of AI mRNA expression in the transformed macrophage cell lines and the detection of AII mRNA only in LPS-stimulated RAW264.7 cells, striking differences were found in the level of arginase activity detected in lysates from the different cell types. These activities ranged from being minimally detectable in unstimulated RAW264.7, P388D1, and J774A.1 cells (results not shown) to a high of 40.3 ± 2.3 nmol/min per 106 cells in anoxic cultured murine macrophages. The greatest arginase activity among the transformed macrophage cell lines was measured in LPS-treated RAW264.7 cells and was 2.35 ± 0.51 nmol/min per 106 cells. If, indeed, arginase serves in macrophages as a modulator of inducible NOS activity through the depletion of extra- or intracellular L-arginine, then none of the transformed cells studied here appears well suited to model for events occurring in primary macrophages. Incidentally, these macrophage cell lines are the most frequently cited in the literature in investigations of the metabolism of L-arginine in macrophages.

                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Effects of varying PO2 on arginase activity and arginine metabolism by cultured macrophages

This laboratory previously highlighted the impact of the hypoxic or anoxic environment of the healing wound on the activities of different enzymes of arginine metabolism (3). Results from those studies demonstrated that rat wound-derived macrophages cultured in an anoxic environment contain more immunoreactive inducible NOS than those cultured in room air and that anoxia fully suppresses inducible NOS activity probably through deprivation of its substrate O2. In addition, a 15-fold increase in the amount of L-arginine metabolized to urea through arginase was observed in wound-derived macrophages cultured overnight under anoxic conditions (3). Examination of the promoter region for rat liver AI (35) revealed the presence of sequences that have been identified as binding sites for nuclear factors known to be induced by hypoxia. These sites include one hypoxia-inducible factor 1 (HIF-1) binding site (26, 40), one activating protein (AP-1) binding site (24), and two functional CCAAT/enhancer-binding protein beta  (C/EBPbeta , NF-IL-6) binding sites (10, 17). These observations led to experiments that confirmed arginase as an hypoxia- or anoxia-inducible gene (Figs. 4 and 5). The increase in immunoreactive AI in cultures treated with cobalt chloride suggests that AI is induced through a pathway involving an O2 sensor similar to that employed by other O2-responsive genes, including erythropoietin, vascular endothelial growth factor, glucose transporter 1, and others (17, 19). In contrast to AI, AII mRNA was actually decreased by hypoxia and anoxia.

With regard to the mechanisms conveying the hypoxic or anoxic signal, preliminary results suggest the involvement of at least one stress-activated protein kinase pathway. This is so because addition of the specific inhibitor of the p38 mitogen-activated protein kinase (MAPK), SB-203580 (23, 42), but not of the MAPK-extracellular regulated protein kinase inhibitor, PD-98059 (15), fully prevented the increase in arginase activity found in hypoxic cultures of wound-derived macrophages (unpublished observations). Work is in progress to complete the elucidation of the second messenger pathways mediating the hypoxic or anoxic response in these cells.

Additional experiments were performed to correlate O2-dependent changes in arginase activity in cell lysates to the actual metabolism of L-arginine by intact cells in culture. A quantitative comparison of results shown in Table 1 for arginase activity in cell lysates and L-arginine metabolism by intact cells reveals that arginase activity greatly exceeds metabolic flux. This discrepancy stems, at least partially, from the conditions employed in the arginase assay, which maximize enzyme activity by providing optimal substrate concentration, alkaline pH, and Mn2+ (25). It was, however, of interest to observe that, in contrast to findings with arginase activity in cell lysates, L-arginine metabolism through arginase was substantially and consistently greater in cells cultured under anoxic conditions than in those cultured in hypoxic conditions. These results suggested that the flux-generating step in L-arginine metabolism through arginase in these cells may be external to the enzyme. In this regard, a family of basic amino acid transporters has recently been identified (reviewed in Ref. 31). One of these transporters, mCAT-2, has been shown to be present in macrophages and induced by IFN-gamma and LPS. Examining the published promoter region of the mCAT-2 gene disclosed the presence of the putative HIF-1 binding site (18). To test the hypothesis that the higher rate of L-arginine metabolism through arginase in cells cultured in anoxic conditions could have resulted from the preferential induction of mCAT-2, its mRNA expression was measured in cells cultured in normoxic, hypoxic, or anoxic conditions. Data in Fig. 6 demonstrate that mCAT-2 mRNA was induced by culture in reduced O2. These results indicate the inducibility of mCAT-2 by low PO2 but do not entirely explain the enhanced processing of L-arginine through arginase in anoxic cultured cells.


View larger version (41K):
[in this window]
[in a new window]
  		Fig. 6.   Hypoxia (1% O2) and anoxia increase mCAT-2 mRNA expression in cultured rat wound-derived and mouse peritoneal macrophages. RNA was prepared and mCAT-2 mRNA and 18S rRNA detected by Northern blot analysis as described under MATERIALS AND METHODS. Densitometric values for 8.5- and 4.5-kb mRNA mCAT-2 normalized to 18S rRNA were as follows: 8.5-kb MCAT-2 transcript in rat wound-derived macrophages: 16.4 for 21% O2, 34.0 for 1% O2, and 95.2 for 0% O2; 4.5-kb MCAT-2 transcript in rat wound-derived macrophages: not detectable in 21% O2, 3.9 for 1% O2, and 8.8 for 0% O2; 8.5-kb MCAT-2 transcript in mouse peritoneal macrophage: 6.1 for 21% O2, 22.9 for 1% O2, and 13.5 for 0% O2; 4.5-kb MCAT-2 transcript in mouse peritoneal macrophages: 3.2 for 21% O2, 13.5 for 1% O2, and 8.2 for 0% O2.

These findings demonstrate considerable variability in the expression of the AI and AII isoforms of arginase in rodent macrophages. In addition, they also add AI and mCAT-2 to the previous description of inducible NOS, tumor necrosis factor-alpha , and interleukin-6 as hypoxia- or anoxia-inducible genes in macrophages (3). In doing so, these observations contribute to the concept that macrophages perceive O2 deprivation as a generalized activating signal (3).

    ACKNOWLEDGEMENTS

This work was supported by National Institute of General Medical Sciences Grants GM-42859 (to J. E. Albina) and GM-51493 (J. S. Reichner), the Anita Allard Memorial Fund, and allocations to the Department of Surgery by Rhode Island Hospital. C. A. Louis is supported in part by National Institute of Environmental Health Sciences Pathobiology Graduate Program Training Grant T32-ES-07272.

    FOOTNOTES

Address for reprint requests: J. E. Albina, Surgical Research, Rhode Island Hospital, 593 Eddy St., Providence, RI 02903.

Received 7 August 1997; accepted in final form 2 December 1997.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Albina, J. E., J. A. Abate, and W. L. Henry, Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. J. Immunol. 147: 144-148, 1991[Abstract].

2.   Albina, J. E., and W. L. Henry, Jr. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50: 403-409, 1991[Medline].

3.   Albina, J. E., W. L. Henry, Jr., B. Mastrofrancesco, B.-A. Martin, and J. S. Reichner. Macrophage activation by culture in an anoxic environment. J. Immunol. 155: 4391-4396, 1995[Abstract].

4.   Albina, J. E., C. D. Mills, A. Barbul, C. E. Thirkill, W. L. Henry, Jr., B. Mastrofrancesco, and M. D. Caldwell. Arginine metabolism in wounds. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E459-E467, 1988[Abstract/Free Full Text].

5.   Albina, J. E., C. D. Mills, W. L. Henry, Jr., and M. D. Caldwell. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144: 3877-3880, 1990[Abstract].

6.   Albina, J. E., and J. S. Reichner. Nitric oxide in inflammation and immunity. New Horiz. 3: 46-64, 1995[Medline].

7.   Brusdeilins, M., R. Kuhner, and K. Schumacher. Purification, affinity to anti-human arginase immunoglobulin-Sepharose 4B and subunit molecular weights of mammalian arginases. Biochim. Biophys. Acta 840: 79-90, 1985[Medline].

8.   Cavalli, R. C., C. J. Burke, S. Kawamoto, D. R. Soprano, and D. E. Ash. Mutagenesis of rat liver arginase expressed in Escherichia coli: role of conserved histidines. Biochemistry 33: 10652-10657, 1994[Medline].

9.   Chen, P. C., and J. D. Broome. Mouse macrophage arginase (40777). Proc. Soc. Exp. Biol. Med. 163: 354-359, 1980[Medline].

10.   Chowdhury, S., T. Gotoh, M. Mori, and M. Takiguchi. CCAAT/enhancer-binding protein beta  (C/EBPbeta ) binds and activates while hepatocyte nuclear factor-4 (HNF-4) does not bind but represses the liver-type arginase promoter. Eur. J. Biochem. 236: 500-509, 1996[Medline].

11.   Cui, S., J. S. Reichner, R. B. Mateo, and J. E. Albina. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54: 2462-2467, 1994[Abstract/Free Full Text].

12.   Currie, G. A. Activated macrophages kill tumour cells by releasing arginase. Nature 273: 758-759, 1978[Medline].

13.   Currie, G. A., L. Gyure, and L. Cifuentes. Microenvironmental arginine depletion by macrophages in vivo. Br. J. Cancer 39: 613-620, 1979[Medline].

14.   Dizikes, G. J., W. W. Grody, R. M. Kern, and S. D. Cederbaum. Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes. Biochem. Biophys. Res. Commun. 141: 53-59, 1986[Medline].

15.   Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686-7689, 1995[Abstract/Free Full Text].

16.   Edlbacher, S., and K. W. Merz. Über den Stoffwechsel der Tumoren. Z. Physiol. Chem. 171: 252-263, 1927.

17.   Estes, S. D., D. L. Stoler, and G. R. Anderson. Normal fibroblasts induce the C/EBPbeta and ATF-4 bZIP transcription factors in response to anoxia. Exp. Cell Res. 220: 47-54, 1995[Medline].

18.   Finley, K. D., D. K. Kakuda, A. Barrieux, J. Kleeman, P. D. Huynh, and C. L. MacLeod. A mammalian arginine/lysine transporter uses multiple promoters. Proc. Natl. Acad. Sci. USA 92: 9378-9382, 1995[Abstract/Free Full Text].

19.   Gleadle, J. M., B. L. Ebert, and P. J. Ratcliffe. Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing. Eur. J. Biochem. 234: 92-99, 1995[Medline].

20.   Goldberg, M. A., G. A. Glass, J. M. Cunningham, and H. F. Bunn. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. USA 84: 7972-7976, 1987[Abstract/Free Full Text].

21.   Goldberg, M. A., and T. J. Schneider. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269: 4355-4359, 1994[Abstract/Free Full Text].

22.   Gotoh, T., T. Sonoki, A. Nagasaki, K. Terada, M. Takiguchi, and M. Mori. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line. FEBS Lett. 395: 119-122, 1996[Medline].

23.   Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994[Abstract/Free Full Text].

24.   Hochachka, P. W., L. T. Buck, C. J. Doll, and S. C. Land. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc. Natl. Acad. Sci. USA 93: 9493-9498, 1996[Abstract/Free Full Text].

25.   Jenkinson, C. P., W. W. Grody, and S. D. Cederbaum. Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 114: 107-132, 1996[Medline].

26.   Jiang, B.-H., E. Rue, G. L. Wang, R. Roe, and G. L. Semenza. Dimerization, DNA binding and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271: 17771-17778, 1996[Abstract/Free Full Text].

27.   Kawamoto, S., Y. Amaya, K. Murakami, F. Tokunaga, S. Iwanaga, K. Kobayashi, T. Saheki, S. Kimura, and M. Mori. Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase. J. Biol. Chem. 262: 6280-6283, 1987[Abstract/Free Full Text].

28.   Kung, J. T., S. B. Brooks, J. P. Jakway, L. L. Leonard, and D. W. Talmage. Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J. Exp. Med. 146: 665-672, 1977[Abstract/Free Full Text].

29.   Le Page, C., J. Sanceau, J.-C. Drapier, and J. Wietzerbin. Differential expression of inducible NO synthase in two murine macrophage cell lines. Immunology 89: 274-280, 1996[Medline].

30.   MacLeod, C. L., K. Finley, D. Kakuda, C. A. Kozak, and M. F. Wilkinson. Activated T cells express a novel gene on chromosome 8 that is closely related to the murine ecotropic retroviral receptor. Mol. Cell. Biol. 10: 3663-3674, 1990[Abstract/Free Full Text].

31.   MacLeod, C. L., and D. K. Kakuda. Regulation of CAT: cationic amino acid transporter gene expression. Amino Acids (Vienna) 11: 171-191, 1996.

32.   Marotta, P., L. Sautebin, and M. Di Rosa. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107: 640-641, 1992[Medline].

33.   Nathan, C. Natural resistance and nitric oxide. Cell 82: 873-876, 1995[Medline].

34.   Oberbaumer, I. Retroposons do jump: a B2 element recently integrated in an 18S rDNA gene. Nucleic Acids Res. 20: 671-672, 1992[Abstract/Free Full Text].

35.   Ohtake, A., M. Takiguchi, Y. Shigeto, Y. Amaya, S. Kawamoto, and M. Mori. Structural organization of the gene for rat liver-type arginase. J. Biol. Chem. 263: 2245-2249, 1988[Abstract/Free Full Text].

36.   Russell, A. S., and U. T. Ruegg. Arginase production by peritoneal macrophages: a new assay. J. Immunol. Methods 32: 375-382, 1980[Medline].

37.   Schneider, E., and M. Dy. Demonstration of a concanavalin A-induced lymphokine enhancing arginase activity. Effect of presensitization of a skin allograft. Eur. J. Immunol. 13: 977-983, 1983[Medline].

38.   Sonoki, T., A. Nagasaki, T. Gotoh, M. Takiguchi, M. Takeya, H. Matsuzaki, and M. Mori. Coinduction of nitric-oxide synthase and arginase I in cultured rat peritoneal macrophages and rat tissues in vivo by lipopolysaccharide. J. Biol. Chem. 272: 3689-3693, 1997[Abstract/Free Full Text].

39.   Tsang, S. S., X. Yin, C. Guzzo-Arkuran, V. S. Jones, and A. J. Davison. Loss of resolution in gel electrophoresis of RNA: a problem associated with the presence of formaldehyde gradients. Biotechniques 14: 380-381, 1993[Medline].

40.   Wang, G. L., and G. L. Semenza. Purification and characterization of hypoxia inducible factor 1. J. Biol. Chem. 270: 1230-1237, 1995[Abstract/Free Full Text].

41.   Wang, W. W., C. P. Jenkinson, J. M. Griscavage, R. M. Kern, N. S. Arabolos, R. E. Byrns, S. D. Cederbaum, and L. J. Ignarro. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210: 1009-1016, 1995[Medline].

42.   Young, P., P. McDonnell, D. Dunnington, A. Hand, J. Laydon, and J. Lee. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39: C67-C69, 1993.

AJP Regul Integr Compar Physiol 274(3):R775-R782
0363-6119/98 $5.00 Copyright © 1998 the American Physiological Society


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Miki, A. Kumar, R. Yang, M. E. Killeen, and R. L. Delude
Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation
Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G840 - G848.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. A. Ionova, J. Vasquez-Vivar, J. Whitsett, A. Herrnreiter, M. Medhora, B. C. Cooley, and G. M. Pieper
Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2178 - H2187.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. A. Robinson, J. E. Baumgardner, V. P. Good, and C. M. Otto
Physiological and hypoxic O2 tensions rapidly regulate NO production by stimulated macrophages
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1079 - C1087.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. D. Nelin, X. Wang, Q. Zhao, L. G. Chicoine, T. L. Young, D. M. Hatch, B. K. English, and Y. Liu
MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C632 - C640.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Horowitz, D. G. Binion, V. M. Nelson, Y. Kanaa, P. Javadi, Z. Lazarova, C. Andrekopoulos, B. Kalyanaraman, M. F. Otterson, and P. Rafiee
Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1323 - G1336.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
L. D. Nelin, L. G. Chicoine, K. M. Reber, B. K. English, T. L. Young, and Y. Liu
Cytokine-Induced Endothelial Arginase Expression Is Dependent on Epidermal Growth Factor Receptor
Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 394 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. G. Chicoine, M. L. Paffett, T. L. Young, and L. D. Nelin
Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L60 - L68.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Endo, S. Oyadomari, Y. Terasaki, M. Takeya, M. Suga, M. Mori, and T. Gotoh
Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung
Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L313 - L321.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Gobert, Y. Cheng, J.-Y. Wang, J.-L. Boucher, R. K. Iyer, S. D. Cederbaum, R. A. Casero Jr., J. C. Newton, and K. T. Wilson
Helicobacter pylori Induces Macrophage Apoptosis by Activation of Arginase II
J. Immunol., May 1, 2002; 168(9): 4692 - 4700.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. E. Albina, B. Mastrofrancesco, J. A. Vessella, C. A. Louis, W. L. Henry Jr., and J. S. Reichner
HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1971 - C1977.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
W. Durante, L. Liao, S. V. Reyna, K. J. Peyton, and A. I. Schafer
Transforming Growth Factor-{beta}1 Stimulates L-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells : Role in Polyamine and Collagen Synthesis
Circulation, February 27, 2001; 103(8): 1121 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. M. Otto and J. E. Baumgardner
Effect of culture PO2 on macrophage (RAW 264.7) nitric oxide production
Am J Physiol Cell Physiol, February 1, 2001; 280(2): C280 - C287.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Kepka-Lenhart, S. K. Mistry, G. Wu, and S. M. Morris Jr.
Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages?
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2237 - R2242.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. P. Gobert, S. Daulouede, M. Lepoivre, J. L. Boucher, B. Bouteille, A. Buguet, R. Cespuglio, B. Veyret, and P. Vincendeau
L-Arginine Availability Modulates Local Nitric Oxide Production and Parasite Killing in Experimental Trypanosomiasis
Infect. Immun., August 1, 2000; 68(8): 4653 - 4657.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. H. Wei, A. T. Jacobs, S. M. Morris Jr., and L. J. Ignarro
IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
Am J Physiol Cell Physiol, July 1, 2000; 279(1): C248 - C256.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Munder, K. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell
Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells
J. Immunol., October 1, 1999; 163(7): 3771 - 3777.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Salimuddin, A. Nagasaki, T. Gotoh, H. Isobe, and M. Mori
Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide
Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E110 - E117.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. S. Reichner, A. J. Meszaros, C. A. Louis, W. L. Henry Jr., B. Mastrofrancesco, B.-A. Martin, and J. E. Albina
Molecular and Metabolic Evidence for the Restricted Expression of Inducible Nitric Oxide Synthase in Healing Wounds
Am. J. Pathol., April 1, 1999; 154(4): 1097 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. A. Louis, V. Mody, W. L. Henry Jr., J. S. Reichner, and J. E. Albina
Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R237 - R242.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Morris Jr., D. Kepka-Lenhart, and L.-C. Chen
Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E740 - E747.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louis, C. A.
Right arrow Articles by Albina, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, C. A.
Right arrow Articles by Albina, J. E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online